Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1964 2
1965 3
1966 4
1967 3
1968 3
1969 1
1972 2
1973 2
1974 3
1975 3
1976 2
1977 1
1978 2
1980 2
1981 1
1982 5
1983 6
1984 1
1985 2
1986 4
1987 3
1988 3
1989 5
1990 9
1991 6
1992 10
1993 7
1994 9
1995 11
1996 5
1997 8
1999 9
2000 3
2001 6
2002 6
2003 4
2004 2
2005 3
2007 2
2008 1
2009 4
2010 6
2011 12
2012 11
2013 14
2014 16
2015 12
2016 17
2017 13
2018 13
2019 19
2020 22
2021 17
2022 17
2023 27
2024 19
2025 17
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ishimura y[au] (239 results)?
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
Jo T, Yoshihara S, Okuyama Y, Fujii K, Henzan T, Kahata K, Yamazaki R, Takeda W, Umezawa Y, Fukushima K, Ashida T, Yamada-Fujiwara M, Hanajiri R, Yonetani N, Tada Y, Shimura Y, Nishikii H, Shiba N, Mimura N, Ando J, Sato T, Nakashima Y, Ikemoto J, Iwaki K, Fujiwara SI, Ri M, Nagamura-Inoue T, Tanosaki R, Arai Y. Jo T, et al. Among authors: shimura y. Br J Haematol. 2023 Jul;202(2):256-266. doi: 10.1111/bjh.18831. Epub 2023 Apr 25. Br J Haematol. 2023. PMID: 37096915 Free article.
The thyrotropin receptor.
Kohn LD, Shimura H, Shimura Y, Hidaka A, Giuliani C, Napolitano G, Ohmori M, Laglia G, Saji M. Kohn LD, et al. Among authors: shimura y. Vitam Horm. 1995;50:287-384. doi: 10.1016/s0083-6729(08)60658-5. Vitam Horm. 1995. PMID: 7709602 Review.
Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum.
Okayama Y, Takakuwa T, Shimura Y, Imada K, Kosugi S, Hotta M, Fuchida SI, Tanaka H, Uoshima N, Yoshihara S, Kanda J, Shibayama H, Fukushima K, Ohta K, Yagi H, Ito T, Shimazaki C, Matsumura I, Takaori-Kondo A, Hosen N, Hino M, Kuroda J. Okayama Y, et al. Among authors: shimura y. Hematology. 2025 Dec;30(1):2496545. doi: 10.1080/16078454.2025.2496545. Epub 2025 Apr 28. Hematology. 2025. PMID: 40296514 Free article.
Azacitidine-associated acute interstitial pneumonitis.
Kuroda J, Shimura Y, Mizutani S, Nagoshi H, Kiyota M, Chinen Y, Maegawa S, Kobayashi T, Matsumoto Y, Horiike S, Taniwaki M. Kuroda J, et al. Among authors: shimura y. Intern Med. 2014;53(11):1165-9. doi: 10.2169/internalmedicine.53.1971. Epub 2014 Jun 1. Intern Med. 2014. PMID: 24881742 Free article.
Real-world data of polatuzumab vedotin with bendamustine and rituximab for Japanese relapsed and refractory DLBCL: a multicenter retrospective study.
Fujino T, Okamoto H, Nishiyama D, Hayata H, Sasaki N, Kobayashi T, Maekura C, Kuwahara-Ota S, Takimoto-Shimomura T, Shimura K, Kawaji-Kanayama Y, Inoue Y, Chinen S, Isa R, Tsukamoto T, Mizutani S, Shimura Y, Kaneko H, Nakao M, Fuchida S, Takahashi R, Uchiyama H, Uoshima N, Kuroda J; Kyoto Clinical Hematology Study Group. Fujino T, et al. Among authors: shimura y. Leuk Lymphoma. 2025 Aug;66(8):1425-1436. doi: 10.1080/10428194.2025.2483390. Epub 2025 Mar 25. Leuk Lymphoma. 2025. PMID: 40134133
Low platelet counts and low CD4/CD8 ratios at apheresis increase the risk of CAR T-cell manufacturing failure in myeloma.
Jo T, Yoshihara K, Ri M, Tsukada N, Mimura N, Fujii K, Fukushima K, Fujiwara SI, Shimura Y, Haraguchi K, Kato K, Satake A, Yoshida A, Suzuki R, Ikemoto J, Iwaki K, Takeda W, Yonetani N, Tanosaki R, Yamada-Fujiwara M, Kahata K, Nagamura-Inoue T, Yoshihara S, Arai Y. Jo T, et al. Among authors: shimura y. Blood Neoplasia. 2024 Oct 24;2(1):100051. doi: 10.1016/j.bneo.2024.100051. eCollection 2025 Feb. Blood Neoplasia. 2024. PMID: 40546722 Free PMC article.
Primary Cutaneous CD8-positive Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Complicated by Paraneoplastic Encephalitis.
Inoue Y, Tsukamoto T, Mizuhara K, Maekura C, Nakamura T, Okamoto H, Fujino T, Mizutani S, Shimura Y, Maruyama A, Nakanishi M, Tanaka E, Nishida Y, Ishii K, Sonobe Y, Miyagawa-Hayashino A, Kuroda J. Inoue Y, et al. Among authors: shimura y. Intern Med. 2025 Sep 1;64(17):2641-2645. doi: 10.2169/internalmedicine.4988-24. Epub 2025 Feb 1. Intern Med. 2025. PMID: 39894488 Free PMC article.
[Phage RNA--isotope labeling].
Shimura Y. Shimura Y. Tanpakushitsu Kakusan Koso. 1972 Oct:Suppl:25-9. Tanpakushitsu Kakusan Koso. 1972. PMID: 4569515 Review. Japanese. No abstract available.
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registry.
Sakurai M, Arai Y, Goto H, Kim H, Masuda K, Kitawaki T, Fujii N, Shimoyama T, Yoshihara S, Kato J, Ara T, Terakura S, Umezawa Y, Nakazawa H, Ando M, Shimura Y, Kanemura N, Onodera K, Nakashima Y, Tanaka H, Atsuta Y, Kataoka K, Kato K. Sakurai M, et al. Among authors: shimura y. Cytotherapy. 2026 Mar;28(3):102042. doi: 10.1016/j.jcyt.2025.102042. Epub 2025 Dec 24. Cytotherapy. 2026. PMID: 41544566
385 results